ライフサイエンスコーパス: receive

1 Patients received 1 of 2 low-intensity computerised CBT (cCBT; we

2 nts were randomly assigned in a 3:1 ratio to receive 1200 million cells or placebo and assessed for s

3 A total of 3207 ophthalmologists received 13 449 payments totaling $4 454 325 associated

4 a and 5 with paraganglioma/pheochromocytoma) received 148-444 MBq (4-12mCi) of (18)F-MFBG intravenous

5 r-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900

6 ligible patients with relapsed/refractory HL received 2 (cohort 1) or 3 (cohort 2) cycles of weekly B

7 patients with relapsed/refractory MM (RRMM) received 28-day cycles of pembrolizumab, 200 mg IV every

8 About half received 3 cycles of docetaxel followed by 3 cycles of c

9 d fluorouracil (T+CEF), while the other half received 3 cycles of docetaxel plus capecitabine followe

10 2015, 626 patients were randomly assigned to receive 300 mg intravenous zanamivir (n=201), 600 mg int

11 d by symptom onset </=4 days or 5-6 days) to receive 300 mg or 600 mg intravenous zanamivir, or stand

12 hy, HIV-uninfected adults were randomized to receive 4 mg of PENNVAX-G DNA delivered intramuscularly

13 All subjects received 40 mg of rosuvastatin daily for 8 to 12 weeks,

14 Patients received 5 mg/kg belatacept every 2 weeks, and the dosin

15 reakthrough reaction rate in the cohort that received 5-hour intravenous corticosteroid prophylaxis.

16 fected individuals on antiretroviral therapy received 60 mg MGN1703 subcutaneously twice weekly for 4

17 in stratum lacunosum-moleculare exclusively receive a glutamatergic signal.

18 approximately 50%, but for those who do not receive a molecular diagnosis after the initial genetics

19 ion error, whereby the animal perceives they received a better value than anticipated.

20 rget-vessel failure between the patients who received a bioresorbable scaffold and the patients who r

21 all survival was improved among patients who received a complete course of radiotherapy (3086 [estima

22 Both groups received a course of empirical systemic antibiotics (amo

23 diagnosed with early-stage breast cancer and received a CPM increased in many states; however, it did

24 t correlate with the proportion of women who received a CPM.

25 %) of 2071 children in the control group had received a diagnosis of RW from a medical doctor and rec

26 ted with lower odds of reporting ever having received a dilated eye examination.

27 not significantly different in patients who received a high FFP:RBC ratio compared with those who re

28 a high FFP:RBC ratio compared with those who received a low ratio.

29 he radiation dose to staff was low; surgeons received a mean dose of 34 +/- 15 muSv per procedure.

30 n the US, children who died or were delisted received a median 1 pediatric liver offer and waited a m

31 Patients received a median of two (IQR 1-2) previous therapies.

32 bioresorbable scaffold and the patients who received a metallic stent.

33 1 at 2 mg/kg (n = 14) or 4 mg/kg (n = 14) or received a placebo (n = 2/dosing group).

34 Patients received a postal questionnaire asking for control items

35 es of later-born infants born to mothers who received a prepregnancy immunization, are blunted.

36 Among cases, 2343 (3.0%) received a prior >/=2-year supply of PPIs and 1063 (1.4%

37 Ten patients (6 PC, 2 BC, and 2 UBC) received a single intravenous dose of (68)Ga-NOTA-AE105

38 ents infected with HCV genotypes 1, 3, and 4 received a single subcutaneous administration of RG-101

39 ent pairs with allele-level HLA matching who received a single unit umbilical cord blood transplantat

40 Patients received a standardised cervical injection of indocyanin

41 immunomodulatory drug, or both, or who were receiving a salvage ASCT.

42 sive to all previous treatments, and 32 were receiving a salvage ASCT.

43 the psychological trajectories of women who received abortions just under the facility's gestational

44 Seven eyes received additional intravitreal vancomycin after surger

45 Those receiving adjuvant chemotherapy had modestly higher dose

46 mosensory area of the cortical amygdala that receives afferent projections from both the main and acc

47 arily innervated from the LHbL, whereas pVTA receives afferents from LHbM and LHbL.

48 tients with HF and reduced ejection fraction receiving aggressive vasodilator titration.

49 Women with stages I to III breast cancer who received all or part of their treatment at the reporting

50 isorder completed two rtfMRI-nf sessions (18 received amygdalar rtfMRI-nf, 16 received control pariet

51 Eyes were randomly assigned to receive an intravitreal injection of bevacizumab, 1.25 m

52 Black stroke survivors received an average of approximately 11 more hours of ca

53 [SD] age, 32.9 [13.3] years), 18338 (54.3%) received an opioid prescription at discharge.

54 for patients with cystic fibrosis who never received an organ transplant; this strategy prevented 79

55 vaginal ring in patients with early-stage BC receiving an AI; secondary objectives included evaluatio

56 the cost of the test, subsequent treatments received, and health care encounters, was determined.

57 No participants in the scalp cooling group received anthracyclines.

58 All patients received anti-HCV treatment before or after inclusion (w

59 123 patients positive for HBsAg who were not receiving anti-HBV prophylaxis were enrolled.

60 tients with inflammatory bowel disease (IBD) receiving anti-TNF therapy.

61 a diagnosis of RW from a medical doctor and received antiasthma treatment (relative risk, 1.07; 95%

62 n 58%, and 66% of children in this age group received antibiotics.

63 PVT recanalization than patients who did not receive anticoagulants (71% vs 42%, respectively; P < .0

64 therapy in patients with ischemic stroke who received anticoagulation with NOACs versus those on warf

65 e of their status, for 90% of those aware to receive antiretroviral therapy (ART), and for 90% of tho

66 Among patients who received antitoxin (n = 193), 23 (12%) reported an adver

67 Participants who received antivascular endothelial growth factor therapie

68 y; 11 patients discontinued the study before receiving any study treatment.

69 When the receiving arm is charged with KCN, transport is much fas

70 ections) were recorded, both in patients who received ASCT.

71 Of the 49 authors evaluated, 40 received at least 1 reported industry payment, 31 accept

72 ithin a month of birth through 15 months who received at least 3 doses of diphtheria-tetanus-acellula

73 afety analyses included all participants who received at least one dose (partial or complete) of stud

74 33 patients randomly assigned treatment, 207 received at least one dose of MABp1 and 102 at least one

75 All randomly assigned patients who received at least one dose of study drug during the main

76 All patients who received at least one dose of study drug were included i

77 and safety was assessed in all patients who received at least one dose of study treatment.

78 commenced drug and included all patients who received at least one dose of venetoclax.

79 This analysis used all data received at NRG Oncology through April 12, 2015.

80 ntation (ASCT) whereas PET-positive patients received augICE before ASCT.

81 tinel lymph node (SLN) metastases should not receive axillary lymph node dissection (ALND).

82 pneumonia in the study period; 1019 (71.9%) received beta-lactam monotherapy and 399 (28.1%) receive

83 ived beta-lactam monotherapy and 399 (28.1%) received beta-lactam plus macrolide combination therapy.

84 Most patients received bioprosthetic valves (AVR+ARE: 73.4% versus AVR

85 irty-three patients received perindopril, 31 received bisoprolol, and 30 received placebo.

86 ing blood stored for 30 to 42 days and those receiving blood stored for 10 to 19 days was -0.2% (95%

87 30-day cumulative mortality between patients receiving blood stored for 30 to 42 days and those recei

88 rons in stratum lucidum and stratum radiatum receive both signals, while those in stratum lacunosum-m

89 The mean proportion of routine vaccine doses received by children younger than 24 months of age was 4

90 dispersal but may also concentrate the dose received by organisms, which subsequently ingest the sta

91 re the first to capture the incoming signals received by the vibrissae of a live seal and show that t

92 tients meeting study criteria, 18 611 (5.9%) received care in patient-centered medical homes.

93 g for hospitalized patients, including those receiving care in specialist palliative care units.

94 g transplant patients diagnosed with IA that received caspofungin therapy when compared with azole-tr

95 iety disorder, or separation anxiety and who received CBT, pharmacotherapy, or the combination.

96 controls if they were treated for lymphoma, received combination chemotherapy, and did not develop t

97 y, SSI occurred in 8/346 (2.3%) patients who received combination prophylaxis versus 4/100 (4.0%) pat

98 In very high-risk patients receiving combination haploidentical single-unit cord bl

99 rginally reduced in ILC2-deficient mice that received combined DEP+HDM, it was abolished in DEP+HDM-e

100 Patients received complete preoperative and postoperative ophthal

101 Thirty-four (34%) of 101 patients receiving concomitant ITP medication discontinued 1 or m

102 n as ice-templating, is a technique that has received considerable attention in recent years to produ

103 Optimal percolation has received considerable attention in the context of isolat

104 isual search, is a crucial function that has received considerable attention in the literature.

105 essions (18 received amygdalar rtfMRI-nf, 16 received control parietal rtfMRI-nf).

106 A total of 63506 eligible patients (88.6%) received CRT-D at the time of device implantation.

107 1%) received upfront surgery and 584 (55.9%) received CRT.

108 ults As of October 13, 2016, 18 patients who received D + T 150/2 remained in the study (13 [24%] of

109 00 Rtx-treated patients and 103 patients who received daily St-Cp We monitored patients with standard

110 e clinical response and survival in patients receiving de novo versus upgrade CRT defibrillator thera

111 dial tegmental nucleus (RMTg), a region that receives dense projections from the LHb and projects str

112 ), patients who had stage 3 to 5 CKD or were receiving dialysis (3 trials), or postmenopausal women w

113 Although both types of neurons receive direct input from entorhinal cortex onto their d

114 l as a promising therapy for cancer patients receiving Dox treatment.

115 ignificantly greater proportion of women who received each elagolix dose met the clinical response cr

116 Patients receiving EC-D reported significantly more stomatitis, m

117 se, EGFR-TKI resistance mutation, failure to receive EGFR-TKI after WBRT/SRS, or insufficient follow-

118 igible women were randomly assigned (1:1) to receive either a single-tablet regimen of dolutegravir p

119 ate were randomly assigned in a 2:1 ratio to receive either adalimumab (at a dose of 20 mg or 40 mg,

120 e esophageal eosinophilia were randomized to receive either BOS 2 mg or placebo twice daily for 12 we

121 omisation using a random number generator to receive either clemastine fumarate (5.36 mg orally twice

122 n or adolescents) underwent randomization to receive either enhanced prophylaxis (906 patients) or st

123 to women previously randomized (1:1:1:1) to receive either GBS vaccine at dosages of 0.5, 2.5, or 5.

124 3396 patients with venous thromboembolism to receive either once-daily rivaroxaban (at doses of 20 mg

125 ) by an interactive voice-response system to receive either oral lenalidomide (2.5 mg/day) or matchin

126 e computer-generated randomisation system to receive either oseltamivir (75 mg), amantadine (100 mg),

127 ed randomisation sequence (blocks of six) to receive either two intranasal doses (0.25 mL per nostril

128 study of patients with BSI due to ESBL-E who received empiric treatment with OADs or carbapenems was

129 ater long-term reduction in HbA1c than those receiving enalapril.

130 this study; 270 patients were randomized to receive eravacycline, and 271 patients were randomized t

131 cycline, and 271 patients were randomized to receive ertapenem.

132 data to compare patients listed with HCC who received exception points versus patients listed with LA

133 US hospitals receive financial penalties for excess risk-standardized

134 cute lymphoblastic leukaemia who were due to receive first or second salvage treatment were randomly

135 Patients receiving first-line or subsequent dasatinib or nilotini

136 the great amount of attention CH3NH3PbI3 has received for its solar cell application, intrinsic prope

137 s its activity according to the influence it receives from other regions.

138 Thirty-five patients (nine who had received GBCA gadopentetate dimeglumine injections previ

139 CB2R ligands have therefore received great attention, and different molecular scaffo

140 ologically confirmed MZL of all subtypes who received >/=1 prior therapy with an anti-CD20 antibody-c

141 ered vaccinated during pregnancy if Tdap was received >/=14 days before delivery; trimester was calcu

142 arly fluoroquinolone (FQ) use was defined as receiving >/=5 doses during the first month of treatment

143 ior >/=2-year supply of PPIs and 1063 (1.4%) received H2RAs (without PPI use).

144 Participants received half their standard TKI dose (imatinib 200 mg d

145 18 089 adults receiving HIV medical care who participated in the Medic

146 secondary health services to ensure they are receiving holistic care.

147 d twenty two well-controlled asthma patients receiving ICS or ICS/LABA were assessed for physical and

148 No contact who received IG PEP developed measles; effectiveness of IG P

149 afety was generally similar between patients receiving immediate treatment and those receiving placeb

150 Patients who received inclisiran had dose-dependent reductions in PCS

151 eneity of element distributions recently has received increased attention in soil science due to its

152 ant-derived proteins as delivery systems has received increasing interest.

153 via an interactive voice response system to receive inotuzumab ozogamicin (starting dose 1.8 mg/m(2)

154 The SCN also receives input from other retinorecipient brain regions,

155 ic rats but not in rats with type 1 diabetes receiving insulin supplementation that did not restore n

156 Participants receiving insulin therapy had greater hazard of infectio

157 For the 20 patients who received intensive therapy, there was no difference betw

158 rom the perspective of Peruvian surgeons who received international training.

159 ardiac surgery with evidence of early AKI to receive intra-aortic MSCs (AC607; n=67) or placebo (n=68

160 atients with relapsing multiple sclerosis to receive intravenous ocrelizumab at a dose of 600 mg ever

161 of patients, with highest rates among those receiving intravenous chemotherapy with high chemotherap

162 STA and VIVID randomized 872 DME patients to receive intravitreal aflibercept injection (IAI) 2 mg ev

163 Children 2 weeks to 17 years receiving invasive mechanical ventilation for lower resp

164 oven indication for a PPI should continue to receive it in the lowest effective dose.

165 omized into 1 of 2 treatment groups: Group A received IVB (2.5 mg/0.1 mL) 1-3 days before PPV, while

166 g/0.1 mL) 1-3 days before PPV, while Group B received IVB (2.5 mg/0.1 mL) 5-10 days before PPV.

167 The LMCI participants who received IVIG performed better on Alzheimer's Disease As

168 P. berghei ANKA infection compared to those receiving KO bone barrow (P < 0.001).

169 east one prior irinotecan-containing therapy received labetuzumab govitecan once weekly at 8 and 10 m

170 Groups receiving lifestyle-based interventions offering 52 or m

171 tions of healthcare outcomes and quality has received little attention.

172 Eligible patients received live zoster vaccine at investigators' discretio

173 Patients with polyneuropathy who were receiving long-term opioids had multiple functional stat

174 t, where cells located deeper inside tissues receive lower irradiance than cells closer to the surfac

175 have reported that black and Hispanic adults receiving maintenance dialysis survive longer than non-H

176 gue-Dawley rats weighing approximately 400 g received mechanical ventilation for 60 minutes according

177 vational study over 3 months of all patients receiving mechanical ventilation in 36 intensive care un

178 re less likely than males (13698 [24.4%]) to receive medications (P < .001), as were non-Hispanic bla

179 of 313 fluid foci in 50 eyes of 25 patients receiving MEK inhibitors for treatment of their metastat

180 age for ASCT in a clinical trial and instead received melphalan at 200 mg/m(2) intravenously over 30

181 ial properties, in particular stiffness, has received much less attention.

182 velopment of a whole-organism vaccine is now receiving much scrutiny.

183 The patients received multidisciplinary medical follow-up expected to

184 veness of CGM in adults with type 2 diabetes receiving multiple daily injections of insulin.

185 d vasopressin modulated neural activity when receiving negative feedback on task performance from a s

186 m the 2006-2012 National Cancer Database who received neoadjuvant chemoradiotherapy followed by surgi

187 , 270 patients from 63 sites in 11 countries received nivolumab, and 265 were evaluated for activity.

188 prostate cancer (Gleason pattern 3) who had received no previous treatment were randomly assigned (1

189 enrolled in Medicaid had 198% higher odds of receiving no glaucoma testing compared with whites posse

190 ients with breast cancer who are at risk for receiving nonguideline breast cancer treatment, which pr

191 r eligible patients with infectious diseases receiving nonpreferred therapy due to severity of their

192 on mediated by retinal horizontal cells that receive nonselective input from L and M cones.

193 , allowing for simultaneous transmission and receiving of signals through the device.

194 inical trials in children with persistent AA receiving omalizumab therapy and observational studies f

195 s regular corticosteroids were randomised to receive once daily, inhaled budesonide 400 mug (those ag

196 ipants aged 6 to 11 years were randomized to receive once-daily tiotropium 5 mug (2 puffs of 2.5 mug)

197 e with HER2 and ER negative tumors, who will receive one of the widely-accepted chemotherapy regimens

198 ng those receiving tailored advice and those receiving only general advice.

199 Both groups could receive open-label LAI for 84 additional days.

200 , patients were randomly assigned (1:1:1) to receive oral rivaroxaban (2.5 mg twice a day) plus aspir

201 Participants received oral cabotegravir 30 mg tablets or matching pla

202 0.39-0.64) readmission rates vs children who received other regimens (cephalosporin and macrolide vs

203 Wild-type (WT) and B cell-deficient mice received ovalbumin (OVA) intranasally before mating.

204 dala were markedly reduced when participants received painful thermal stimuli following hypnotic anal

205 In contrast, the midbrain, which receives parallel retinal input, encodes orientation poo

206 icocortical connections, the auditory cortex receives parallel thalamocortical projections from the m

207 esult in 76 more hospitals being eligible to receive penalties.

208 Results Thirty-three patients received perindopril, 31 received bisoprolol, and 30 rec

209 ts to one of three groups in blocks of 15 to receive placebo (normal saline), low-dose ketamine (0.5

210 er birth, patients were randomly assigned to receive placebo or hydrocortisone (0.5 mg/kg twice per d

211 who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or diseas

212 ents who received tofacitinib and in one who received placebo, and adjudicated cardiovascular events

213 perindopril, 31 received bisoprolol, and 30 received placebo.

214 he two primary end points than did those who received placebo.

215 ive who received tofacitinib and in none who received placebo; as compared with placebo, tofacitinib

216 ents receiving immediate treatment and those receiving placebo in the deferred treatment group.

217 nd to HZV-unvaccinated beneficiaries who had received pneumococcal vaccination (secondary analysis).

218 onstrated superior survival for patients who received postoperative chemoradiotherapy with bolus fluo

219 ng IR radiation is detected by comparing the received power levels in the bolometer pairs correspondi

220 Rats receiving PPAR-gamma antagonists displayed proteinuria a

221 The Niagara River receives PPCPs from different wastewater treatment plant

222 Medial DA neurons received predominantly GABAergic currents mediated by pr

223 s associated with a 4.5-fold greater odds of receiving preferred beta-lactam therapy (95% confidence

224 with resected pancreatic cancer who did not receive preoperative therapy should be offered 6 months

225 Final OS among patients not receiving previous pelvic radiotherapy was 24.5 months v

226 axel (n = 41) or cabazitaxel (n = 22); 44.4% received prior potent androgen receptor-targeted therapy

227 scores worsened by 3 months for patients who received radical prostatectomy (36.2 [95% CI, 30.4-42.0]

228 erall proportion of beneficiaries that first received ranibizumab for neovascular AMD was 35%, and va

229 in neoplastic mast cells and will hopefully receive recognition by health authorities in the near fu

230 Among patients who received red blood cell transfusions, receipt of a trans

231 We included 28 patients who received regorafenib from our pharmacy.

232 127 patients in the AIM Dysplasia trial, 119 received RFA and met inclusion criteria.

233 By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo

234 cancer center was better in patients who had received rituximab in addition to the chemotherapy regim

235 rwent transplantation than in the group that received RVD alone (50 months vs. 36 months; adjusted ha

236 abetes and HFrEF enrolled in PARADIGM-HF who received sacubitril/valsartan had a greater long-term re

237 Fewer complications were noted in eyes receiving sclerostomy (5/29, 17.2%) as compared to contr

238 18 countries and randomly assigned (1:1) to receive second-line oral buparlisib (100 mg once daily)

239 left ventricular assist device patients who received secondary prophylaxis with octreotide after the

240 s have bipolar extension of dendrites, which receive segregated inputs from two ears and display rapi

241 The amount of warning received showed evidence of being protective against sym

242 rameters, to increase preterm birth risk has received significant attention worldwide, but the findin

243 Subjects received single doses of dofetilide, quinidine, ranolazi

244 in patients with first-episode psychosis who received social recovery therapy plus early intervention

245 l audiometry were randomly assigned (1:1) to receive sodium thiosulfate or observation (control group

246 In men with a negative PSMA who received SRT, 85% (n = 23/27) demonstrated a treatment r

247 In the Fabry mice receiving SRT but not ERT, BH4 deficiency was restored,

248 s maraviroc to a contemporary control cohort receiving standard GVHD prophylaxis alone.

249 sed individuals, particularly those who have received stem cell transplants.

250 All patients who received study intervention (injection of dye), regardle

251 ssigned 251 patients, in a 2:1:1:1 ratio, to receive subcutaneous tocilizumab (at a dose of 162 mg) w

252 ment was completed in February 2005, and she received subsequent routine care.

253 received surgery earlier, 13731 patients who received surgery after 24 hours had a significantly high

254 13731 propensity-score matched patients who received surgery earlier, 13731 patients who received su

255 ) immunoreactive puncta suggesting that they receive synaptic input from bipolar cells.

256 Four thousand one hundred seventeen patients received T2 MELD exceptions, of which 245 (6%) had false

257 inical and welfare providers comparing those receiving tailored advice and those receiving only gener

258 Patients who received TC6 plus bevacizumab on NSABP B-46-I/USOR 07132

259 pairs) and in siblings born after the women received Tdap vaccine (group B; 58 mother-infant pairs).

260 depression, we randomly assigned patients to receive tDCS plus oral placebo, sham tDCS plus escitalop

261 179 (64%) were skin test eligible; 43 (24%) received testing and none were allergic.

262 ncluded in the study, 1 randomly assigned to receive the intervention.

263 ible) seem to be the skeletal subspaces that receive the main effect of the treatment.

264 characterized by highest level of alcohols, received the highest score for aroma and sweetness in th

265 esions were assigned to MiStent, of whom 697 received the index procedure, and 695 patients with 993

266 esions were asssigned to Xience, of whom 690 received the index procedure.

267 All patients received the same chemotherapy regimen of bortezomib and

268 A total of 507 eyes of 289 patients receiving the Artisan Myopia or Artisan Toric (Ophtec B.

269 i-V1V2 IgG responses than in adult vaccinees receiving the moderately effective RV144 vaccine.

270 Fewer injections were required in patients receiving the T&E (8.7) versus monthly (11.1) regimen, w

271 Notably, in the subset of patients who had received three or fewer prior lines of therapy (n = 23),

272 Most people with dementia do not receive timely diagnosis, preventing them from making in

273 ere not told which type of surgery they were receiving (to ensure masking).

274 d cardiovascular events occurred in five who received tofacitinib and in none who received placebo; a

275 ma skin cancer occurred in five patients who received tofacitinib and in one who received placebo, an

276 In patients with recurrent nasal polyposis receiving topical corticosteroids who required surgery,

277 14 weeks, infants were randomly assigned to receive tOPV (n = 315) or inactivated polio vaccine (IPV

278 3-month intervals, ASP teams at 3 hospitals received training by allergists to offer BLAST for eligi

279 years, with refractoriness, ineligibility to receive treatment with alternative medications, or relap

280 arly breast cancer were randomly assigned to receive treatment with perindopril, bisoprolol, or place

281 Three patients received treatment activities of 5.1-7.5 GBq.

282 13 patients received treatment cycle 2; ten (77%) of the 13 achieved

283 All patients who received treatment were included in an intent-to-treat a

284 imary refractory or relapsed myeloma who had received treatment with bortezomib, an immunomodulatory

285 he results show that women who are currently receiving treatment for ANSD show an over-estimation of

286 limiting side effect experienced by patients receiving treatment for cancer.

287 is substantially higher in children with HIV receiving treatment for tuberculosis (especially without

288 th alternative medications, or relapse while receiving treatment with alternative medications were in

289 outcomes in a subgroup of laser control eyes receiving treatment with intravitreal aflibercept inject

290 survival in multiple cohorts of AML patients receiving treatment with the cytidine nucleoside analogu

291 digm shift in cancer treatment, has recently received tremendous attention.

292 vity surrounded by a porous outer shell have received tremendous research interest owing to their uni

293 tified 1044 patients, among whom 460 (44.1%) received upfront surgery and 584 (55.9%) received CRT.

294 prophylaxis versus 4/100 (4.0%) patients who received vancomycin alone (crude RR 0.58, 95% CI 0.18, 1

295 Patients were randomly assigned 1:1 to receive vandetanib plus gemcitabine (vandetanib group) o

296 has been postulated that the amygdala first receives visual input via a rapid subcortical route that

297 rom 2005 to 2010, the proportion of patients receiving VTE prophylaxis or with an indication that pro

298 ssigned docetaxel, prednisone, and custirsen received weekly doses of custirsen 640 mg intravenously

299 to 8 cups of water per day, the water group received well-defined messages about water through couns

300 GSNOR KO animals receiving WT bone marrow had significantly reduced survi